Precision BioSciences (DTIL) Financials

$7.20

$-0.05 (-0.73%)

As on 10-Sep-2026 12:34EDT

Market cap

$206 Mln

Revenue (TTM)

$45 Mln

P/E Ratio

--

P/B Ratio

4.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	45.06	34.26	68.70	48.73	25.10	115.53
Cost of Revenue	1.35	2.75	4.58	8.26	9.00	--
Gross Profit	45.06	34.26	68.70	48.73	25.10	115.53
Operating Expenses	81.45	86.41	94.86	92.46	87.41	154.91
Operating Profit (EBIT)	-36.40	-52.15	-26.16	-43.74	-62.31	-39.38
Other Income	--	--	--	--	-11.27	8.80
Profit before Tax	-53.62	-46.61	7.17	-42.53	-72.91	-30.60
Provision for Tax	--	--	--	27.24	11.27	0.32
Profit after Tax (Net Income)	-52.73	-45.72	7.17	-61.32	-111.64	-30.60
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-111.64	-30.60

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	45.29	92.25	56.39	18.86	60.43	91.17
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	73.49	53.26	65.02	90.93	118.07	84.35
Current Liabilities	7.14	8.91	14.98	49.99	59.66	35.98
Total Liabilities	133.06	154.42	136.39	159.78	238.17	211.50

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	34.37	35.68	41.40	23.42	39.06	49.74
Current Assets	91.55	118.74	94.99	136.36	199.11	161.75
Total Assets	133.06	154.42	136.39	159.78	238.17	211.50
Total Debt*	28.10	28.81	30.05	31.27	24.96	9.11
Net Current Assets	84.41	109.83	80.01	86.37	139.44	125.77

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-65.84	-58.45	-84.11	-45.75	-10.85
Cash Flow from Investing Activities	--	-0.63	-0.22	5.83	-3.32	-5.80
Cash from Financing Activities	--	95.16	50.45	5.39	94.99	70.52
Net Cash Inflow / Outflow	--	--	--	--	45.91	53.87

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.80	-2.38	1.04	-13.77	-30.18	-15.07
Cash EPS ($)	--	-2.24	1.71	-11.76	-27.75	-10.05
Adjusted Book Value ($)	--	4.81	8.19	4.24	16.34	44.91
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.43	-8.49	-18.89	-12.37	-5.35
Free Cash Flow per Share ($)	--	-3.44	-8.53	-19.40	-13.27	-8.20

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-44.07	10.50	-90.49	-120.25	-39.43
ROE (%)	-76.68	-61.52	19.05	-154.66	-147.28	-45.14
ROA (%)	-41.27	-31.45	4.84	-30.82	-49.65	-16.92
EBIT Margin (%)	-116.07	-131.88	13.03	-82.70	-286.07	-26.37
Net Margin (%)	-117.04	-133.45	10.43	-125.84	-807.38	-24.61
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	3,472.96	-0.50	0.41	0.94	-0.78	3.76
EBIT Growth (%)	31.99	-604.94	122.21	43.87	-135.64	72.05
Net Profit Growth (%)	32.62	-737.98	111.69	45.07	-264.80	71.93
EPS Growth (%)	69.71	-3.29	1.08	0.54	-1.00	0.76
Book Value Growth (%)	-43.18	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.74	3.66	-0.03	-0.04	-0.49
Price / Book Value	4.55	0.86	0.47	0.09	0.07	0.16
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.22	0.17	-2.22	2.61	2.55	5.90
Close Price ($)	7.86	4.16	3.81	10.95	35.70	222.00
High Price ($)	8.82	8.82	19.43	43.50	235.50	498.00
Low Price ($)	3.53	4.02	3.61	8.25	28.50	219.00
Market Cap ($ Cr)	206.18	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.50	0.31	0.53	1.66	0.41	0.10
Short term debt to equity ratio	0.04	0.02	0.02	1.25	0.03	0.02
Current Ratio	12.82	13.32	6.34	2.73	3.34	4.50
Quick Ratio	12.82	--	--	--	3.21	4.01
Interest Coverage	-39.59	-31.78	5.02	-18.07	-64.62	-230.83

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	2.47	26.26	2.87	0.42
Asset Turnover	0.35	0.24	0.46	0.24	0.11	0.64
Receivable days	--	9.05	38.54	50.66	8.79	16.58
Inventory Days	--	--	--	334.15	506.78	--
Payable days	--	106.67	170.77	80.11	36.45	--
Cash Conversion Cycle	--	--	--	304.70	479.12	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.